Search results
Could this FTSE 250 stock double in value by 2030?
Motley Fool UK· 2 days agoChemring (LSE:CHG) is a FTSE 250 company experiencing some whirlwind growth right now. The Romsey-based company, which has a market cap of £1.02bn,...
Liver X receptor inverse agonist SR9243 attenuates rheumatoid arthritis via modulating glycolytic...
Nature· 1 day agoLiver X receptors (LXRs) which link lipid metabolism and inflammation, were overexpressed in experimental rheumatoid arthritis (RA) rats as observed in our previous studies, while suppression ...